Cashu
Century Therapeutics Gains Insights from Clear Street's Expanded Biotechnology Research Initiative
11 months ago
Stocks
Health Care
ipsc
Century Therapeutics
NASDAQ: IPSC
+0.01 (+1.49%)
0.4714
USD
At close at Nov 14, 21:44 UTC
Latest Century Therapeutics News
businesswire.com
Clear Street Launches Healthcare & Biotechnology Equity Research
11 months ago
businesswire.com
Clear Street Launches Healthcare & Biotechnology Equity Research
11 months ago
finance.yahoo.com
Century Therapeutics Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Scientific Officer
about 1 year ago
finance.yahoo.com
GC Therapeutics secures $65m to launch into off-the-shelf iPSC therapy space
about 1 year ago
finance.yahoo.com
Induced Pluripotent Stem Cell (iPSC) Global Industry Report 2024 - Revolutionizing Medicine: The Transformative Power and Commercial Potential of Induced Pluripotent Stem Cells (iPSCs)
about 1 year ago
finance.yahoo.com
Century Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
over 1 year ago
finance.yahoo.com
After losing 17% in the past year, Century Therapeutics, Inc. (NASDAQ:IPSC) institutional owners must be relieved by the recent gain
over 1 year ago
finance.yahoo.com
Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and Programs at 2024 ASGCT Annual Meeting
over 1 year ago
finance.yahoo.com
Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
over 1 year ago
finance.yahoo.com
Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on the Development of a mRNA-Engineered iPSC Line which Mimics Native B2M Expression, via Targeted Insertion of HLA-E at the B2M Locus
over 1 year ago
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.